Participants with Type 2 diabetes and obesity
Ongoing
-
Adelaide SA | Goolwa SA
Effect of a new medication on participants without type 2 diabetes who have obesity and knee OA.
- Closed to screening
- Monthly self-administered injections (similar to Epipen)
- BMI > 30 kg/m²
- Weight-related comorbidities: hypertension, high cholesterol, knee pain / osteoarthritis
Outpatient Visit
- Clinic visits every 2 months
Payment / Remuneration
- Reimbursed for travel